ARCHIVES

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

This article is from The Cancer Letter archive.

Vol. 31 No. 18 | May 6, 2005

Download PDF Visit The Full Archive

Related Articles

Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers

May 31, 2002

Higgins: VA Groups D Have Review; NCI: It’s Ad Hoc

December 2, 1977

Jordan Gutterman Selected To Head Lasker Awards Program

January 4, 1991

Colorado universities install huge NMR magnet. NCI to transfer 5 A Day to CDC.

May 27, 2005

Mayer Will Emphasize Rehab Research While Serving On NCAB

May 24, 1991

Funding Opportunities.

April 19, 2002